Sergio Cesco-Cancian

This inventor holds 16 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Discovery Laboratories, Inc., Ortho-Mcneil Pharmaceutical Corp.. Active years: 2008-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergio Cesco-Cancian. Retrieved from https://idiyas.com/inventor/sergio-cesco-cancian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 4)

% Patents Active = 25.0

CIPO Patents = 4

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 35(Granted Patents)

Company Filing History:

11 out of 2,101

Janssen Pharmaceutica Nv

patents

2 out of 8

Discovery Laboratories, Inc.

patents

2 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

4. 1 out of 6

Windtree Therapeutics, Inc.

patents

Years Active: 2008-2017

Loading Chart...

Areas of Expertise:

Liposomal Surfactants

Pyrimidine Derivatives

Phosphonic Acid Compounds

Serine Protease Inhibitors

Cyclopropyl-Amide Derivatives

Benzamide Derivatives

Synthetic Processes

Lyophilization Techniques

Chemical Synthesis

Pharmaceutical Applications

Drug Development

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9554999 - Lyophilization of synthetic liposomal pulmonary surfactant (2017-01-31),

2. 9359327 - Process for the preparation of substituted pyrimidine derivatives (2016-06-07),

3. 9079884 - Process for the preparation of substituted pyrimidine derivatives (2015-07-14),

4. 9079883 - Process for the preparation of substituted pyrimidine derivatives (2015-07-14),

5. 9079882 - Process for the preparation of substituted pyrimidine derivatives (2015-07-14),

6. 9006432 - Process for the preparation of substituted pyrimidine derivatives (2015-04-14),

7. 8835633 - Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives (2014-09-16),

8. 8748397 - Lyophilization of synthetic liposomal pulmonary surfactant (2014-06-10),

9. 8748396 - Lyophilization of synthetic liposomal pulmonary surfactant (2014-06-10),

10. 8497373 - Phosphonic acid compounds as inhibitors of serine proteases (2013-07-30),

11. 8394804 - Phosphonic acid compounds as inhibitors of serine proteases (2013-03-12),

12. 8309720 - Process for the preparation of substituted pyrimidine derivatives (2012-11-13),

13. 8063206 - Processes for the preparation of cyclopropyl-amide derivatives (2011-11-22),

14. 7795426 - Processes for the preparation of cyclopropyl-amide derivatives (2010-09-14),

15. 7728129 - Processes for the preparation of piperazinyl and diazapanyl benzamide derivatives (2010-06-01),

Title: The Innovative Contributions of Sergio Cesco-Cancian

Introduction

Sergio Cesco-Cancian, based in Bethlehem, PA, is a prominent inventor recognized for his significant contributions to the fields of pharmaceutical innovations and chemical processes. With a total of 16 patents to his name, his work has greatly impacted the development of therapeutic agents and medical technologies.

Latest Patents

One of Sergio's latest patents is related to the lyophilization of synthetic liposomal pulmonary surfactants. This invention details lyophilized pulmonary surfactants that exhibit an increased specific surface area and porosity, alongside methods for their preparation. Another notable patent pertains to processes for the preparation of substituted pyrimidine derivatives. This invention is focused on creating useful intermediates for the synthesis of histamine H receptor modulators, with implications for H4 modulator synthesis.

Career Highlights

Throughout his career, Sergio Cesco-Cancian has held positions at notable pharmaceutical companies, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His work in these organizations has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Sergio has collaborated with esteemed colleagues in his endeavors, including Neelakandha S. Mani and David C. Palmer. These partnerships have fostered an environment of creativity and innovation, enabling significant advancements in their respective fields.

Conclusion

In conclusion, Sergio Cesco-Cancian stands out as a key figure in the realm of pharmaceutical innovations. His numerous patents and collaborations reflect a commitment to enhancing medical solutions and advancing research in critical therapeutic areas. His contributions continue to pave the way for future advancements in the industry.

Profile summary based on public USPTO records.